Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C., talks about the problems associated with generic HIV PrEP drug markups and potential ways to fix it.

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Lupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at ...

Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in ...

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

Mirroring the Sensex, NSE Nifty50 also ended lower by 113.15 points or 0.49 per cent at 23,092.20. The Nifty50 recorded a day ...

Mumbai: Global pharma major Lupin Limited has announced the launch of Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, ...

Gardasil has been one of Merck's top growth drivers aside from blockbuster cancer treatment Keytruda. (Image Credits: Pixabay) U.S. drugmaker Merck & Co on Wednesday announced that its human ...

What Is an HIV Rash? An HIV rash is irritated skin that affects people who have HIV. It can be itchy, red or purple, or painful. Most people who have HIV get a rash at some point. It’s a common ...